• Clayton, Dubilier & Rice engaged John Chiminski, former Catalent chair and CEO, as an operating advisor focused on healthcare investments.
• Chiminski led Catalent through its 2014 IPO; enterprise value rose to USD 18.5 billion before Novo Holdings’ USD 16.5 billion deal in 2024.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Clayton, Dubilier & Rice LLC published the original content used to generate this news brief on July 07, 2026, and is solely responsible for the information contained therein.